首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话15274084725)
药品名称:
商品名称:
药品NDC:
报告期内:
-
格式:2020-5-3
NDC包装id:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话15274084725)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Thiamine B1 100mg/mL
HUMAN COMPOUNDED DRUG
26436-1963
Hybrid Pharma
2021/2/1 0:00:00
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
26436-1963-3
Methionine/Inositol/Choline Chloride
HUMAN COMPOUNDED DRUG
72627-2418
Empower Pharmacy
2021/2/1 0:00:00
INOSITOL; CHOLINE CHLORIDE; METHIONINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL; 50 mg/1 mL; 25 mg/1 mL
72627-2418-1
L-Arginine HCl
HUMAN COMPOUNDED DRUG
72627-2414
Empower Pharmacy
2021/2/1 0:00:00
ARGININE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
72627-2414-1
Glutathione
HUMAN COMPOUNDED DRUG
72627-2403
Empower Pharmacy
2021/2/1 0:00:00
GLUTATHIONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
72627-2403-1
Dexpanthenol
HUMAN COMPOUNDED DRUG
72627-2412
Empower Pharmacy
2021/2/1 0:00:00
DEXPANTHENOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
250 mg/1 mL
72627-2412-1
B-Com 100
HUMAN COMPOUNDED DRUG
26436-5471
Hybrid Pharma
2021/2/1 0:00:00
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
26436-5471-3
Edetate Calcium Disodium
HUMAN COMPOUNDED DRUG
72833-821
ASP Cares
2021/2/1 0:00:00
EDETATE CALCIUM DISODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
300 mg/1 mL
72833-821-30
Vancomycin 1.25g added to 250mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-264
Apollo Care, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
71170-264-25
Vancomycin 1.75g added to 500mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-194
Apollo Care, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.5 mg/1 mL
71170-194-50
Vancomycin 1.5g added to 250mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-184
Apollo Care, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
6 mg/1 mL
71170-184-25
Vancomycin 1.5g added to 500mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-185
Apollo Care, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3 mg/1 mL
71170-185-50
Vancomycin 2g added to 500mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-204
Apollo Care, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/1 mL
71170-204-50
Vancomycin 2.5g added to 500mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-224
Apollo Care, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
71170-224-50
Trisodium Citrate 0.5 (0.5/4L)
HUMAN COMPOUNDED DRUG
69374-910
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
TRISODIUM CITRATE DIHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5.3 g/1 L
69374-910-04
Lidocaine HCL 50 mg/5 mL
HUMAN COMPOUNDED DRUG
69374-985
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/5 mL
69374-985-05
Albuterol Sulfate 0.5%
HUMAN COMPOUNDED DRUG
69374-309
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
ALBUTEROL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
69374-309-20
Succinylcholine Chloride 20 mg/mL
HUMAN COMPOUNDED DRUG
69374-300
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
69374-300-05
Succinylcholine Chloride 20 mg/mL
HUMAN COMPOUNDED DRUG
69374-300
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
69374-300-10
Bupivacaine 3mg/ml, Ketorolac 1.2mg/ml, Ketamine 1.2mg/ml
HUMAN COMPOUNDED DRUG
69374-514
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE; KETOROLAC; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
60 mg/1 mL; 60 mg/1 mL; 150 mg/1 mL
69374-514-50
del Nido Cardioplegia
HUMAN COMPOUNDED DRUG
69374-984
Nephron Sterile Compounding Center, LLC
2021/2/1 0:00:00
POTASSIUM CHLORIDE; SODIUM BICARBONATE; LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.19 g/1 mL; 1.04 g/1 mL; 123 mg/1 mL
69374-984-10
首页
(current)
3
(current)
4
(current)
5
(current)
6
(current)
7
(current)
8
(current)
9
(current)
10
(current)
11
(current)
12
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:33068302000535
医药代理商群1:
医药代理商群2:
医药代理商群3: